Escolar Documentos
Profissional Documentos
Cultura Documentos
, SpS(K)
1
Is a chronic, progressive neurodegenerative
disorder with a multifactorial etiology.
It is superseded only by Alzheimer’s Disease
as the most common neurodegenerative
disorder
2
# per 100,000
Alzheimer’s disease 4,000,000 1,450
Parkinson’s disease 1,000,000 360
Frontotemporal dementia 40,000 14
Pick’s disease 5,000 2
Progressive supranuclear palsy 15,000 5
Amyotrophic lateral sclerosis 20,000 7
Huntington’s disease 30,000 11
Prion disease 400 <1
3
• Prevalence of 0.3 % in the US population
• 1 – 2% of all persons > 65 yrs old
• 4 – 5% of all persons > 85 yrs old
• In US : > 1 million have diagnosis of Parkinsons – this is
greater than the combined number of MS, ALS, and
muscular dystrophy patients added together
• Usual age at onset – early 60s
• 10% of all those affected are < 45 yrs old – referred to as
young onset Parkinsons
• 40, 000 new cases of PD will diagnosed this year
• Lifetime risk of Parkinsons for men : 2.0%
• Lifetime risk for women : 1.3%
• Incidence of the disease is lower in African Americans
than in Caucasians in the USA
4
1. Tremor at rest Diagnostic Criteria :
Definite Parkinsons :
2. Rigidity at least two of these
3. Bradykinesia features must be
4. Loss of postural present, one of them
being # 1 or # 2
reflexes
Probable : Feature #
5. Flexed Posture 1 or feature # 2 is
6. Freezing (Motor present
Block) Possible : at least
two of features # 3 –
6 must be present
5
Freezing is also known as motor block
Most often affects the legs when walking, but it
can also affect the arms and eyelids
Freezing consists of a sudden, transient inability
to move
It typically causes hesitation when initiating
walking & sudden inability to move feet when
turning or walking thru narrow passages – such as
doors or elevators – or when patients are about
to reach a target destination
Freezing is thought to related to noradrenergic
deficiency related to degeneration of the locus
coeruleus
6
Determine when freezing occurs in
relationship to activity, the environment,
time of day & dosing of PD medications
UPDRS assesses freezing when walking &
falling as related to freezing
0 = Normal
1 = Rare freezing when walking, may have
start hesitation
2 = Occasional freezing when walking
3 = Falls an average of once daily related to
freezing
7
Pharmacological
Nonpharmacological
8
Pharmacological
Sometimes when a patient is undermedicated,
increasing the dose of PD medications may
alleviate freezing
“Off” phase, end – dose freezing responsds to
shortening the time between levodopa doses and
taking the next dose at earlier time, addition of
a COMT inhibitor or agonist
If clinical response to levodopa is inadequate,
treatment is to increase the respective levodopa
dose
Liquid levodopa as “rescue therapy” can be
effective given relatively short onset of
symptoms
9
Nonpharmacological
Provide a referral to a physical therapist to
assesss freezing, provide gait training & instruct
the patient in how to use cueing & increase
safety with ambulation.
Share tips with the patient & family on how to
break a freeze, as described in “Cueing Tips” in
the next section.
10
Cuing Tips – General Strategies
First stop trying to continue the movement that
elicits the freezing. Then initiate a different
movement
Auditory
Use a metronome or music and walk to the beat.
Bigger steps may help reduce freezing occurs with
walking, first stop walking & then try marching or
reaching before resuming walking again
Visual
Look through, not directly at, doorways
Step over a marked line or spot on the floor
Use a device designed for gait freezing
Verbal
Count one, two, three, four, five, out loud
March-left, right, left, right
11
Dyskinesia are involuntary movements, often
writhing or choreiform & are dance like in
nature
Motor complications of long term levedopa
theraphy
Can certainly appear earlier with use
dopaminergic medications.
may affect any part of the body : the
extremities, trunk, neck & facial muscles
12
Pharmacological
Nonpharmacological
13
Pharmacological
Reduction of dose or frequency levodopa
Dose reduction of dopamine agonists
Amantadine (symmetrel) provides consistent
but only partial reductio of dyskinesia; dosing
often begins with 100 mg twice a day (BID), the
is increased to 100 mg three times a day (TID) as
needed
Peak-dose dyskenesias : reduce amount of
levodopa IR and consider discontinuing
adjunctive selegiline or COMT inhibitors,
Consider addition of amantadine
Rapid motor fluctuations with alternating
dyskinesias and “off” states, consider addition of
an agonist (use adequate dose and avoid rapid
titration of dose)
14
Nonpharmacological
Patient/family education should include training on
how to assess & document the presence of dyskinesia.
Patients & family should be taught the difference
between dyskinesia & tremor so that symptoms can
be reported effectively
Patient/family should be aware of the importance of
maintaining a safe environment when dyskinesia :
ambulation safety, driving limitation & modification
of activities of dailt living
Individuals with moderate to severe dyskinesia often
have a significant decrease in dyskinesia followong
DBS surgery.
Psychological support should be provided to assist the
patient/family in copig with the stigma associated
with dyskinesia.
15
Freezing
is the inability to initiate or continue a
movement.
it is usually a problem of gait in PD but can
be observed with other motor tasks
gait freezing strongly impacts a person’s
ability to move safely with ease &
confidence.
Dyskenesia
Choreiform with without dystonia : usually
levodopa – induced
Ussually peak - dose (off-on-dyskinesia-on-
off) and rarely biphasic (off-dyskinesia-on-
dyskinesia-off) 16
Dyskenesia